Federal Circuit remands PTAB decision over LA Biomedical patent

01-03-2017

Federal Circuit remands PTAB decision over LA Biomedical patent

Mari / iStockphoto.com

The US Court of Appeals for the Federal Circuit has remanded a decision to the Patent Trial and Appeal Board (PTAB) concerning a dispute between LA Biomedical Research Institute and Eli Lilly.


Federal Circuit, IPR, inter partes review, patent, Eli Lilly, LA Biomedical Research, PTAB, Patent Trial and Appeal Board, Cialis

LSIPR